Brief: Evotec Says Receives Non-Binding Takeover Offer From Halozyme At 11 Euros/Share
14/11/2024 21:53
Nov 14 (Reuters) - Evotec SE EVTG.DE :
* EVOTEC SE - RECEIVES NON-BINDING TAKEOVER OFFER FROM
HALOZYME AT
EUR 11.00 PER SHARE
Source text: ID:nEQ4ZfcbLa
Further company coverage: EVTG.DE
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Evotec SE
See all newsEvotec up 7% in early trade after 9-month revenue, earnings beat
Brief: Evotec Says Preliminary Nine-Month 2026 Results Above Market Expectations
Brief: Evotec Initiates Phase 1 Trial For Jst-018 Antibodies Targeting Orthopoxviruses
Brief: EVOTEC Q2 Group Revenues €143.50 Mln
Brief: Evotec And Odyssey Therapeutics Enter AI-Enabled R&D Collaboration In Autoimmune And Inflammatory Diseases